Abiomed Inc (NASDAQ:ABMD)

Delayed Data
As of Sep 13
 -1.61 / -0.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 240.00, with a high estimate of 255.00 and a low estimate of 215.00. The median estimate represents a +28.75% increase from the last price of 186.41.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -52.38%
Growthannually -9.88%


Growthquarterly -0.54%
Growthannually 16.41%
Key to the earnings and sales forecast charts.